206 related articles for article (PubMed ID: 7004689)
1. Experimental drug-induced aplastic anaemia.
Haak HL
Clin Haematol; 1980 Oct; 9(3):621-39. PubMed ID: 7004689
[No Abstract] [Full Text] [Related]
2. Aplastic anaemia. II. Drug-induced aplastic anaemia.
Böttiger LE; Westerholm B
Acta Med Scand; 1972 Oct; 192(4):319-21. PubMed ID: 5081069
[No Abstract] [Full Text] [Related]
3. Phenylbutazone, oxyphenbutazone and aplastic anaemia.
Böttiger LE
Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472
[No Abstract] [Full Text] [Related]
4. In vitro evidence of drug action in aplastic anemia.
Vincent PC
Blut; 1984 Jul; 49(1):3-12. PubMed ID: 6378281
[No Abstract] [Full Text] [Related]
5. Drug-induced aplastic anaemia: clinical aspects.
Heimpel H; Heit W
Clin Haematol; 1980 Oct; 9(3):641-62. PubMed ID: 7004690
[No Abstract] [Full Text] [Related]
6. Editorial: Drug-induced aplastic anaemia.
Lancet; 1974 Feb; 1(7851):251-2. PubMed ID: 4130254
[No Abstract] [Full Text] [Related]
7. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.
Chaplin S
Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881
[No Abstract] [Full Text] [Related]
8. Aplastic anaemia. I. Incidence and aetiology.
Böttiger LE; Westerholm B
Acta Med Scand; 1972 Oct; 192(4):315-8. PubMed ID: 5081068
[No Abstract] [Full Text] [Related]
9. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II.
Chaplin S
Adverse Drug React Acute Poisoning Rev; 1986; 5(3):181-96. PubMed ID: 3538824
[No Abstract] [Full Text] [Related]
10. The pathogenesis of aplastic anemia.
Appelbaum FR; Fefer A
Semin Hematol; 1981 Oct; 18(4):241-57. PubMed ID: 6117130
[No Abstract] [Full Text] [Related]
11. Phenylbutazone, oxyphenbutazone labeling revised.
FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
[No Abstract] [Full Text] [Related]
12. Phenylbutazone and oxyphenbutazone: time to call a halt.
Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755
[No Abstract] [Full Text] [Related]
13. [Study of the pathogenic factors of aplastic anemia].
Zhang RF; Lin GF; Xu LP
Zhonghua Nei Ke Za Zhi; 1986 Jan; 25(1):13-6, 62-3. PubMed ID: 3731950
[No Abstract] [Full Text] [Related]
14. Letter: Drug induced aplastic anaemia.
Casey TP
Lancet; 1974 Oct; 2(7885):906-7. PubMed ID: 4137767
[No Abstract] [Full Text] [Related]
15. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
Inman WH
Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
[TBL] [Abstract][Full Text] [Related]
16. [Present aspects of bone marrow lesions due to drugs (author's transl)].
Hausmann K; Skrandies G; Sachtleben P
MMW Munch Med Wochenschr; 1974 Sep; 116(38):1621-6. PubMed ID: 4215965
[No Abstract] [Full Text] [Related]
17. Role of chloramphenicol reduction products in aplastic anemia.
Pazdernik TL; Corbett MD
Pharmacology; 1980; 20(2):87-94. PubMed ID: 7384192
[TBL] [Abstract][Full Text] [Related]
18. [Idiopathic and drug-induced acquired aplastic anemia].
Keiser G; Walder HR
Schweiz Med Wochenschr; 1970 Apr; 100(16):697-702. PubMed ID: 5524822
[No Abstract] [Full Text] [Related]
19. [Current aspects of iatrogenic lesions of the bone marrow].
Hausmann K; Skrandies G; Sachtleben P
Minerva Med; 1976 Nov; 67(55):3583-90. PubMed ID: 995304
[TBL] [Abstract][Full Text] [Related]
20. [On an animal model of aplastic anemia induced by busulfan (author's transl)].
Yamagishi M; Niki T; Hiraoka A; Dohmae N; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):771-4. PubMed ID: 7234293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
